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ABSTRACT
Velvet antler is believed to have body strengthening, immunomodulatory and anti-aging effects. It is used in Chinese
commercial functional foods and nutraceuticals. The antioxidant activity of the aqueous extract of velvet antler (AEVA) from
Cervus elaphus Linnaeus was evaluated with DPPH-radical scavenging, FRAP, Fe2+-chelating and inhibition of linoleic acid autoxidation assays. AEVA showed antioxidant activity in all four assays. After removal of protein from AEVA, the antioxidant activity
was significantly elevated. A semi-preparative HPLC equipped with a C18 column was used for further separation of the non-protein components (AEVA-S). Identification of the most active fraction (AEVA-SII) of AEVA-S was accomplished by LC/MS, HPLC
and UV/Vis analyses. The HPLC chromatogram showed five main peaks identified as nucleotides (3′-CMP, 2′-CMP, 3′-UMP and
2′-UMP) and hypoxanthine. Nucleotides in AEVA-SII exhibited no free-radical scavenging and ferric-reducing activity. Only UMP
exhibited Fe2+-chelating activity which accounted for 34.75% of the total Fe2+-chelating activity of AEVA-SII. The results indicated
that other unidentified components with antioxidant activity were present in AEVA-SII.
Key words: velvet antler, nucleotides, antioxidant, HPLC, LC/MS

INTRODUCTION
Velvet antler, the whole cartilaginous antler in a precalcified stage, is commonly known as “lu rong” in China.
As a renewable resource, it is a mainstay of traditional
Chinese medicine (TCM) and secondary only to ginseng
in importance. Medicinal uses for velvet antler have
been recorded in the Compendium of Materia Medica
since the 16th century. It has been used in enriching vital
energy, nursing the blood, strengthening the kidney
and prolonging life for thousands of years. Velvet antler
is reported to have pharmacological activities such as
haemotopoietic (1), growth-stimulating (2), anti-aging (3),
immunomodulatory and anti-inflammatory effects(4).
In China, velvet antler has been used in medicine, nutraceuticals and functional foods. In particular,
aqueous decoction is one of its major uses in TCM.
* Author for correspondence. Tel: +86-10-6273-7129;
Fax: +86-10-6234-7334; E-mail: baopingji@gmail.com

The aqueous extract of velvet antler (AEVA) contains
proteins, polypeptides, free amino acids, glycosaminoglycans and nucleotides (5). In recent years, there has been
an increasing awareness of the benefits of velvet antler.
Interest in the discovery of its functional components has
risen dramatically. However, the functional components
of velvet antler are still not well known.
The antioxidant properties of TCM have generated
great interest in researchers. The properties are commonly
postulated to play an important role in preventing diseases
caused by oxidative stress, such as aging, coronary heart
disease and cancer. Antioxidant analysis on the organic
extract of velvet antler has been carried out. The extract
demonstrated a range of antioxidant-related activities,
including the ability to protect carbohydrates from hydroxyl
radical-mediated degradation, scavenge hydroxyl radical
and inhibit lipid peroxidation(6). However, no research has
focused on the antioxidant activity of AEVA and the active
components are still not clear.
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The present study focused on two aspects: (1) preparation and evaluation of the antioxidant activity of
AEVA, AEVA-S (supernatant of AEVA without protein)
and its fractions; (2) identification of the main components in AEVA-S fractions and investigation of their
roles in the antioxidant activity of AEVA-S fractions.

MATERIALS AND METHODS
I. Materials
Velvet antlers (Cervus elaphus Linnaeus) were
obtained from male red deer that were bred at the
Daxing’an mountain range (Heilongjiang, China). Samples
were freeze-dried, homogenized, and stored at 4°C until
usage. DPPH, TPTZ, linoleic acid, ferrozine, Trolox
and BHT were purchased from Sigma-Aldrich (St.
Louis, MO, U.S.A.). Cytidylic acid (2′- and 3′- mixture)
was purchased from Cambrian Chemicals (London,
U.K.). 3′-Uridylic acid was purchased from TCI (Tokyo,
Japan). Hypoxanthine was purchased from Ameresco
(Solon, Ohio, U.S.A.). HPLC grade acetonitrile was from
Mallinckrodt Baker (Phillipsburg, New Jersey, U.S.A.).
Other chemicals of analytical grade were purchased from
Beijing Chemical Reagent Co., Ltd. (Beijing, China).
II. Preparation of AEVA
Submicron powder of velvet antler (50 g) was
extracted three times with 1 L of distilled water in
boiling-water bath for 2 h. The aqueous extract was
obtained by filtering the mixture through Whatman No.
1 filter paper under diminished pressure. The filtrate
was then concentrated at reduced pressure. The yield of
AEVA was 38.45% (w/w) of the dried sample.
III. Removal of Protein from AEVA
Anhydrous ethanol was added to concentrated
AEVA solution to obtain a final concentration of 75%.
The suspension was left overnight at 4°C, and then centrifuged at 12,000 rpm for 20 min. The supernatant was
freeze-dried. The freeze-dried powder was referred to as
AEVA-S and stored at 4°C until usage.
IV. Separation of AEVA-S by Semi-preparative HPLC
The separation was performed on a HPLC system
(LC-10ATvp, Shimadzu, Kyoto, Japan) equipped with two
pumps and a diode array detector (DAD). The column
used for separation was a Kromasil C18 column (10 mm
× 250 mm, 5 μm, SE-445 80 Bohus, Sweden). The sample
solution was filtered through a 0.22-μm syringe filter
before HPLC analysis. Eluent A was 0.1% trifluoroacetic
acid (TFA) in acetonitrile and eluent B was 0.1% TFA in
water. Samples were loaded onto the column through a

500-μL loop valve. The gradient elution conditions were
set as follows: 0 - 30 min, 0 - 5% A; 30 - 40 min, 5 - 50%
A; 40 - 50 min, 50% A. The flow rate was set at 3.0 mL/
min, with the temperature set at 30°C and the detection
was carried out at a wavelength of 260 nm.
V. Identification of Antioxidants from AEVA-S
(I) UV/Vis Spectrum Analysis
The UV/Vis absorption spectra were obtained
at room temperature using a UV spectrometer (GBC,
Australia) and 1-cm cuvette. The spectrum was acquired
from 200 to 500 nm.
(II) HPLC/DAD Analysis
Using the same system as the semi-preparative
HPLC, analytical HPLC was performed using a ZORBAX
SB-C18 column (4.6 mm × 250 mm, 5 μm, Agilent Technologies, U.S.A.). Eluent A was 0.05% formic acid in
acetonitrile and eluent B was 0.05% formic acid in water.
The elution was started with 100% eluent B. The ratio of
eluent A in the system was increased linearly from 0 to
3.5% over 20 min. The flow rate was set at 0.8 mL/min,
with the temperature set at 30°C and the detection was
carried out at a wavelength of 260 nm. A sample loop of
20 μL was used for the injection.
(III) HPLC/ESI/MS Analysis
The Agilent 1100 series LC/MSD Trap used in this
study was equipped with an ion trap MS detector with
electrospray ionization (ESI) interface. The system used
the same column as that in the analytical HPLC analysis.
Flow rate was set at 0.8 mL/min, and detection wavelength was set at 260 nm. The flow splitting of the HPLC
eluate introduced into the ESI interface was 3 : 1. The ESI
voltage was 3.5 kV, and a mass range (m/z) of 50 - 1000
was scanned in positive full ion monitoring mode. The
nebulizing gas (nitrogen) pressure was set at 35 psi and the
drying gas (nitrogen) was held at 8 L/min for ionization.
VI. Antioxidant Assays
(I) DPPH-radical Scavenging Assay
DPPH-radical scavenging activity was measured by
the method of Brand-Williams et al.(7). Briefly, 3.9 mL of
DPPH-methanol solution (6 × 10 -5 M, about 0.025 mg/mL)
was added to 0.1 mL of sample methanol solution. The
mixture was shaken and incubated at room temperature for 60 min in the dark, and the decrease in absorbance at 517 nm was determined at the end of incubation period with a spectrophotometer. Trolox was used as
positive control. From the obtained values, μmol Trolox
equivalents/g sample was calculated for each sample.
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(II) FRAP Assay
The ferric-reducing ability of plasma (FRAP)
method described by Benzie and Strain(8), was used to
measure the ferric ion reducing capacity. Briefly, 3.0 mL
of freshly prepared FRAP reagent was warmed to 37°C,
0.1 mL of sample was then added, along with 0.3 mL of
H 2O. The mixture was shaken and incubated at 37°C in
the water bath for 30 min. Then, the absorbance of the
developed reaction mixture was measured at 595 nm.
Trolox was used as positive control. The results were
expressed as μmol Trolox equivalents/g sample.
Working FRAP reagent was prepared by mixing
25 mL of 0.3 M acetate buffer (pH 3.6), 2.5 mL of 10 mM
TPTZ solution (dissolved in 40 mM HCl) and 2.5 mL of
20 mM FeCl 3·6H 2O.
(III) Metal Chelating Assay
The Fe2+ -chelating ability was determined
according to the method of Decker and Welch(9). The Fe2+
was monitored by measuring the formation of ferrous
iron-ferrozine complex. The test sample was mixed with
2 mM FeCl 2 and 5 mM ferrozine at a ratio of 50 : 1 : 2
(v/v/v). The mixture was shaken and incubated at room
temperature for 10 min. The absorbance of the resulting
solution was measured at 562 nm. A lower absorbance of the reaction mixture indicated a higher Fe2+ chelating ability. EDTA was used as a standard metal
chelating agent. From the obtained values, μmol EDTA
equivalents/g sample was calculated for each sample.
(IV) Inhibition of Linoleic Acid Autoxidation
The lipid peroxidation inhibition activity was
measured in the linoleic acid system(10). An aliquot
of 1 mL of sample solution, was added to a solution of
linoleic acid (0.13 mL), 99.8% ethanol (10 mL) and 10 mL
of 0.2 M sodium phosphate buffer (pH 7.0). The mixture
was made up to 25 mL with distilled water and incubated
at 40°C in the dark. The reaction mixture (0.1 mL) was
mixed with 4.7 mL of ethanol (75%), 0.1 mL of ammonium thiocyanate (30%) and 0.1 mL of ferrous chloride
(20 mM in 3.5% HCl). After the mixture was stirred for
3 min, the peroxide value was determined by reading
the absorbance at 500 nm. The degree of oxidation was
measured every 24 h for 12 days. Butylated hydroxytoluene (BHT, 0.1 mg/mL) and Trolox (0.5 mM) were used
as positive controls.
VII. Statistical Analysis
Each set of experiments was carried out with three
replicates. Data were expressed as means ± S.D. Statistical analysis was performed by the Duncan test at
the 95% significance level to express the difference
between two groups. p < 0.05 was considered statistically

significant. The correlation was calculated under Pearson
correlation coefficient (2-tailed) in bivariate correlations.
Analysis was done with SPSS 13.0 (SPSS, Inc., Chicago,
IL, U.S.A.).

RESULTS AND DISCUSSION
I. Antioxidant Activities of AEVA and AEVA-S
The antioxidant activities of AEVA and AEVA-S may
not be attributed to a single mechanism. Therefore, four
methods were used to evaluate the antioxidant activities
from different aspects: the DPPH-radical scavenging assay
was used to evaluate the free-radical scavenging capacity
of antioxidants; the FRAP assay was used to reflect the
ferric-reducing activity of antioxidants; the metal chelating assay was used to evaluate the Fe2+-chelating ability
and demonstrate the inhibitory effect on the generation
of radicals (e.g. Fenton reaction); the inhibition of linoleic
acid autoxidation assay was used to measure the activity of
antioxidants to inhibit lipid peroxidation.
The antioxidant activities of AEVA and AEVA-S
are shown in Table 1 and Figure 1. From the results, it
was obvious that the antioxidant activity of AEVA-S
was significantly higher than that of AEVA. The DPPHradical scavenging activity and reducing power of
AEVA-S were 18.66 and 47.64 μmol TE/g, respectively.
These two values were 4 and 2.5 times of those of AEVA.
AEVA and AEVA-S showed similar Fe2+ -chelating abilities, suggesting that both of them were able to capture
ferrous before the formation of ferrozine.
In the linoleic acid system, the antioxidant activities of AEVA and AEVA-S were observed and compared
with BHT and Trolox (Figure 1). As seen in Figure 1,
the linoleic acid autoxidation in the blank was increased
gradually over 12 days of oxidative reaction. Lower
absorbance at 500 nm indicated higher lipid peroxidation
inhibition. Both AEVA and AEVA-S exhibited similar
lipid peroxidation inhibitory activities to those of BHT
and Trolox. The products of the lipid peroxidation (such
as malondialdehyde) could cause damage to proteins
and DNA(11). It was suggested that the compositions of
AEVA-S may be beneficial to prevent aging, cardiovascular diseases, cholesterol lowering and other lipid
peroxidation processes.
Overall, AEVA-S possessed a higher antioxidant
activity than AEVA. The results suggested that the nonprotein components were responsible for the antioxidant activity of AEVA. Thus, AEVA-S was selected for
further study.
II. Separation of AEVA-S by Semi-preparative HPLC
In order to determine the main components responsible for antioxidant activity of AEVA-S, AEVA-S was
subjected to fractionation with a semi-preparative HPLC
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Table 1. Antioxidant activities of AEVA, AEVA-S and its fractions
Yield1 (mg/g)

DPPH-radical scavenging activity
(μmol TE2/g sample)

Reducing power
(μmol TE2/g sample)

Fe2+-chelating ability
(μmol EE3/g sample)

--

4.04 ± 0.69f

18.94 ± 0.56e

9.65 ± 0.19bc

AEVA-S

135.27

18.66 ± 0.51e

47.64 ± 0.46cd

9.89 ± 0.28b

AEVA-SI

10.17

21.37 ± 0.01d

46.22 ± 0.76d

9.17 ± 0.37c

AEVA-SII

7.75

35.48 ± 0.06a

86.03 ± 3.94b

11.02 ± 0.27a

AEVA-SIII

6.27

21.33 ± 0.37d

44.72 ± 2.83d

9.75 ± 0.19b

AEVA-SIV

9.75

24.20 ± 0.51b

100.26 ± 4.43a

11.00 ± 0.36a

AEVA-SV

79.74

22.53 ± 0.30c

51.85 ± 3.33c

6.56 ± 0.33d

Samples
AEVA

Data (means ± S.D., n = 3) in the same column followed by a different letter are significantly different (p < 0.05). DPPH-radical scavenging
activity and reducing power were measured at a concentration of 25 mg/mL, and Fe2+-chelating ability was measured at a concentration of 5
mg/mL.
1.
Yield: Extract yield was expressed as mg/g of the dry weight of AEVA.
2.
TE: Trolox equivalents.
3.
EE: EDTA equivalents.

Absorbance at 500 nm

2.0
Control
AEVA
AEVA-S
BHT
Trolox

1.5
1.0
0.5
0.0

0

2

4

6

8

10

12

14

Time (days)

Figure 1. Linoleic acid autoxidation inhibition activities of AEVA
and AEVA-S. The concentration of AEVA and AEVA-S was 10 mg/
mL. BHT (0.1 mg/mL) and Trolox (0.5 mM) were used as positive
controls. Data are presented as means ± S.D. (n = 3).

C18 column. As shown in Figure 2, the separated peaks
were divided into five fractions (I, II, III, IV and V). The
profiles of AEVA-SIV and AEVA-SV were more complicated than the other three fractions. AEVA-SV probably
contained more hydrophobic compounds, which were
therefore eluted with a high concentration of acetonitrile. The yields of AEVA-S (I-V) are shown in Table 1.
They ranged from 2.41 to 30.66 mg/g of the dry weight of
velvet antler.
III. Antioxidant Activities of the Fractions of AEVA-S
The antioxidant activities of the five fractions of
AEVA-S were evaluated by DPPH-radical scavenging,
FRAP and metal chelating assays. Table 1 shows the
antioxidant activities of AEVA-S (I-V) with different
methods. The results varied according to the type of
assay used.

In our study, the DPPH-radical scavenging activity
was expressed as Trolox equivalents per gram of sample
on a dried basis (Table 1). DPPH-radical scavenging
activities of AEVA-S and its fractions were in the order:
AEVA-SII > AEVA-SIV > AEVA-SV > AEVA-SI ≈
AEVA-SIII > AEVA-S. AEVA-SII exhibited significantly
higher DPPH-scavenging activity than the other fractions. The stable radical DPPH has been widely used for
the determination of primary antioxidant activity. The
effects of the antioxidants on DPPH are based on their
ability to donate a hydrogen atom to DPPH(12). The study
indicated that AEVA-SII acted as a potent hydrogen
donor and could serve as free-radical scavenger, acting
possibly as primary antioxidant.
Antioxidants can be explained as reductants.
As shown in Table 1, the ferric reducing activities of
AEVA-S and its fractions were in the order: AEVASIV > AEVA-SII > AEVA-SV > AEVA-S ≈ AEVA-SI
> AEVA-SIII. Both AEVA-SII and AEVA-SIV showed
approximately 2-fold higher ferric-reducing ability than
AEVA-S. In this assay, the AEVA-SII again showed relatively high antioxidant activity among all the fractions.
The presence of reductants in AEVA-SII caused the
reduction of the Fe3+ -TPTZ complex to the blue ferrous
(Fe2+) form. The reducing activity of a compound might
serve as a significant indicator of its potential antioxidant activity. There was a significant correlation between
DPPH and FRAP assay of AEVA and its fractions (r =
0.791, p < 0.05). The higher the DPPH-scavenging
activity, the higher the FRAP activity of the samples.
The chelating activity was measured against Fe2+
and reported as EDTA equivalents (Table 1). In this assay,
the Fe2+-chelating activities of AEVA-S and its fractions
were in the order: AEVA-SII ≈ AEVA-SIV > AEVA-S >
AEVA-SIII > AEVA-SI > AEVA-SV. Ferrous ions can
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IV. Identification of Main Components from AEVA-SII
HPLC/ESI/MS analysis of AEVA-SII is shown in
Figure 4. Using LC/MS, AEVA-SII was separated into
five main components, and the total ion current chromatogram of AEVA-SII is shown in Figure 4A. The corresponding (+) ESI-MS spectra of peaks 1-5 from Figure 4A
are shown in Figure 4B-4F. Peak 1 gave four main ions
at m/z 324.0, 346.0, 647.0 and 669.0 (Figure 4B). Data
inspection enabled the identification of m/z 324.0 and
346.0 as [M+H]+ and [M+Na]+, while m/z 647.0 and 669.0
were identified as [2M+H]+ and [2M+Na]+. The molecular
weight of peak 1 is thus confirmed to be 323.0 Da. Peak
2, which had a similar mass spectrum as peak 1 (Figure
4C), was considered as the isomer of peak 1. Peak 3 gave
one main characteristic [M+H]+ ion at m/z 137.0 (Figure
4D). The molecular weight of peak 3 is confirmed to be
136.0 Da. Peak 4 showed six main ions at m/z 325.0, 347.0,
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stimulate lipid peroxidation by Fenton reaction, and also
accelerate peroxidation by decomposing lipid hydroperoxides into peroxyl and alkoxyl radicals that can themselves abstract hydrogen and perpetuate the chain reaction of lipid peroxidation(13). Chelating agents may serve
as secondary antioxidants because they reduce the redox
potential, thereby stabilizing the oxidized form of the
metal ions(14). Therefore, it was suggested that the Fe2+chelating effects of AEVA-S and its fractions would be
somewhat beneficial to protect against oxidative damage.
According to the results of the antioxidant assays,
AEVA-SII exhibited strong antioxidant activities in all
three assays, especially in DPPH-radical scavenging and
Fe2+ -chelating assays. As shown in Figure 3, AEVASII produced effective DPPH-radical scavenging,
reducing, and Fe2+ -chelating activities in a dose-dependent manner. These results suggested that AEVA-SII
contained active components responsible for the antioxidant activity.

5

Concentration (mg/mL)

Time (min)

Figure 2. Semi-preparative HPLC chromatogram at 260 nm of
AEVA-S. The chromatographic conditions were described in the
Materials and Methods section.

0

(C)

1.00
0.80
0.60
0.40
0.20
0.00

0

1
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Concentration (mg/mL)

Figure 3. Correlation between AEVA-SII concentrations and absorbance in antioxidant assay. (A) DPPH-radical scavenging activity (r =
-0.976, p < 0.01), (B) Reducing power (r = 0.999, p < 0.01), (C) Fe2+chelating ability (r = -0.989, p < 0.01). Data are presented as means ±
S.D. (n = 3).

369.0, 649.0, 671.0 and 693.0 (Figure 4E). Being similar to
peak 1, data inspection enabled the identification of m/z
325.0, 347.0 and 369.0 as [M+H]+, [M+Na]+ and [M+2NaH]+, while m/z 649.0, 671.0 and 693.0 were identified as
[2M+H]+, [2M+Na]+ and [2M+2Na-H]+. The molecular
weight for peak 4 is thus confirmed to be 324.0 Da. Peak
5, which had a similar mass spectrum as peak 4 (Figure
4F), was considered as the isomer of peak 4. The fact that
peaks 4 and 5 exhibited [M+2Na-H]+ peaks indicated that
a freely exchangeable proton existed on these compounds.
The main chemical components of velvet antler are
proteins, polypeptides, free amino acids, glycosaminoglycans, fatty acids, cholesterol, phospholipids and
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nucleotides(5). According to the molecular weight of the
possible components of velvet antler, peaks 1 and 2 were
tentatively determined as CMP; peak 3: hypoxanthine;
and peaks 4 and 5: UMP.
HPLC techniques have become the most applicable

1

(A)

2.0

1.0

5

4

2

94.2
0

15

647.1

324.0

110.1119.1

1

10

(B)

137.0

3

5

Time (min)

0.8

50

150

100

(E)

1.2

347.0

0.2

346.0

95.1
0.0

0.8

Intens (x106)

112.1

0.4

200

435.0

400

0.6

0.2

629.0 669.0
600

325.0 369.0

137.1

0.0

800

671.0

213.0

0.4

200

Intens (x105)

112.1
669.0

0.50
0.25
289.2

84.2
0.00

700.0

489.0

200

400

600

800

600

347.0

1.00

647.1

0.75
0.50 (A)
500

3
179.0

0.25
400

(mAU)

Intens (x106)

(F)

1.25
346.1
324.0

0.75

693.0
715.0

m/z (amu)

(C)

1.00

649.0

400

m/z (amu)
1.25

200

m/z (amu)

1.0

0.6

Intens (x107)

3

2

0.0

(D)

4

Intens (x106)

Intens (x107)

3.0

procedures for the rapid determination of nucleotides(15).
Some monophosphate nucleotides have already been
identified by HPLC with ion-pairing reagents coupled
to MS(16,17). In order to further verify the above speculation, the retention times of peaks 1-5 were compared
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Figure 5. HPLC/DAD chromatograms of AEVA-SII and standards at 260 nm. The chromatographic conditions were described in the Materials
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and Methods
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with nucleotide standards by analytical HPLC analysis.
The HPLC chromatograms of the four selected standards (3′-CMP, 2′-CMP, 3′-UMP and hypoxanthine)
and AEVA-SII are shown in Figure 5. By comparing
AEVA-SII and standard mixture profiles, peaks 1, 2, 3
and 4 had the same retention time with 3′-CMP, 2′-CMP,
hypoxanthine and 3′-UMP, respectively. UMP exists
as three isomers: 2′-UMP, 3′-UMP and 5′-UMP. In our
study, 5′-UMP was eluted earlier than peaks 1-5 (data not
shown) and peak 4 was identified as 3′-UMP. Aussenac et
al.(16) separated 21 reference monophosphate nucleotides
by reversed-phase HPLC, and discovered that the separation of the isomers of UMP was in the elution order of 5′-,
3′-, and 2′-UMP. Accordingly, it was suggested that peak
5 in our study was 2′-UMP.
The UV/Vis spectra of peaks from AEVA-SII separated by HPLC (Figure 5) and their corresponding
standards are shown in Figure 6. Every compound
has its characteristic UV/Vis spectrum. The common
purine and pyrimidine bases all absorb in the region of
250 - 280 nm, and the absorption spectra of the

nucleosides and nucleotides are similar to those of the
free bases (18). The UV/Vis absorption spectra of all
samples were measured in 0.05% formic acid (pH 2.8).
By comparing UV/Vis spectra of peaks 1-5 with their
corresponding standards, it was found that peaks 1 and
2 shared the same absorption maximum/minimum with
CMP (λ max at 278 nm, λ min at 240 nm; Figure 6A, 6B);
peak 3: the same with hypoxanthine (λ max at 248 nm,
λ min at 220 nm; Figure 6C); and peaks 4 and 5: the same
with UMP (λ max at 259 nm, λ min at 230 nm; Figure 6D).
Based on the results of LC/MS, HPLC and UV/Vis
analyses, five compounds of AEVA-SII were unequivocally identified as (1) 3′-CMP, (2) 2′-CMP, (3) hypoxanthine, (4) 3′-UMP and (5) 2′-UMP. Quantification was also
carried out by integration of the peak areas using external
standard calibration. The amount of 3′-CMP, 2′-CMP,
hypoxanthine, 3′-UMP and 2′-UMP in AEVA was 0.88,
0.30, 1.29, 1.80 and 0.68 mg/g of dry weight, respectively.
Foods in the raw state contain a very low level of free
nucleotides. This level increases markedly after heating
due to enzymatic breakdown of the endogenous tissue
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Figure 6. UV/Vis spectra of peaks from AEVA-SII separated by HPLC (Figure 5) and standards. (A) Peak 1, (B) Peak 2, (C) Peak 3, (D) Peaks
4 and 5.
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Table 2. Contribution of nucleotides to the total antioxidant activity of AEVA-SII.

Samples

1

Yield
(mg/g)

DPPH-radical
scavenging activity
(μmol TE2/g sample)

Reducing power
(μmol TE2/g sample)

2+

Fe -chelating ability
(μmol EE3/g sample)

Contribution to total
Fe2+-chelating ability5
(μmol EE3/g
sample)

(%)

AEVA-SII

7.75

35.48 ± 0.06

86.03 ± 3.94

11.02 ± 0.27

CMP4

1.18

N.A.

N.A.

N.A.

--

--

Hypoxanthine

1.29

N.A.

N.A.

N.A.

--

--

3′-UMP

1.80

N.A.

N.A.

13.27 ± 0.10

3.83 ± 0.23

34.75

Data are presented as means ± S.D. (n = 3). DPPH-radical scavenging activity and reducing power were measured at a concentration of 25
mg/mL, and Fe2+-chelating ability was measured at a concentration of 5 mg/mL. N.A. means no activity.
1.
Yield: Extract yield was expressed as mg/g of the dry weight of AEVA.
2.
TE: Trolox equivalents.
3.
EE: EDTA equivalents.
4.
CMP: Cytidylic acid (2′- and 3′- mixture).
5.
Contribution of 3′-UMP to Fe2+-chelating ability of AEVA-SII was measured at a concentration of 1.2 mg/mL

RNA(19). Thus, we speculated that relative high amounts
of nucleotides in AEVA are due to the degradation of
nucleic acids in velvet antler during the decoction process.
V. Antioxidant Activities of Nucleotides from AEVA-SII
To evaluate the antioxidant activities of nucleotides from AEVA-SII, the above three antioxidant assays
(DPPH-radical scavenging, FRAP and metal chelating
assays) were used. Table 2 shows the antioxidant activities
of CMP, hypoxanthine and UMP with different methods.
They exhibited no DPPH-radical scavenging and ferric
reducing activities, both individually and in combination (Table 2). Of the nucleotides (3′-CMP, 2′-CMP, hypoxanthine, 3′-UMP and 2′-UMP) found in AEVA-SII, the
combined amount was approximately 64% of AEVA-SII.
It was indicated that some other unidentified components existed in AEVA-SII that might have free-radical
scavenging activity. To the best of our knowledge, few
studies have been reported on the free-radical scavenging
activity of nucleotides. However, Wang et al.(20) reported
that nucleotides (5′-AMP, 5′-CMP, 5′-GMP and 5′-UMP)
can all effectively scavenge superoxide anion radicals in
a luminal-potassium ferricyanide-pyrogallol system, but
the antioxidant mechanism was not clarified.
Some researchers found that nucleotides could act as
metal-ion chelators(21,22). In our study, CMP and hypoxanthine showed no Fe2+ -chelating activity. However,
3′-UMP showed Fe2+ -chelating activity. It suggested
that 3′-UMP could inhibit oxidant reaction catalyzed by
iron-ion. Table 2 shows the calculated antioxidant activities of the individual nucleotides, and their contribution
to the total antioxidant activity. The calculated Fe2+ chelating activity of 3′-UMP was only 34.75% of the total
measured value. The remaining Fe2+ -chelating activity
was presumably due to unidentified components.

In brief, AEVA-SII had relatively high free-radical
scavenging and Fe2+ -chelating activities. However, nucleotides, the main components in AEVA-SII, showed minor
contribution to the total antioxidant activity of AEVASII. The results suggested that other effective antioxidants in AEVA-SII need to be separated and identified.

CONCLUSIONS
Our present study demonstrated that AEVA,
AEVA-S and its fractions had antioxidant activity in
different assays in vitro including: DPPH-radical scavenging, FRAP, metal chelating and inhibition of linoleic
acid autoxidation assays. Nucleotides (3′-CMP, 2′-CMP,
3′-UMP and 2′-UMP) and hypoxanthine were identified
from AEVA-SII as its main components by LC/MS, HPLC
and UV/Vis analyses. Although UMP exhibited Fe2+chelating activity, nucleotides in AEVA-SII had minor
contribution to the total antioxidant activity of AEVA-SII.
Other unidentified components with antioxidant activity
might be present in AEVA-SII. Moreover, CMP and UMP
in AEVA were firstly reported in velvet antler. To further
unravel potentially antioxidant activity of AEVA, other
unidentified active components should be further clarified.
A scientific research using animal models is necessary to
determine their effects in animal systems.
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ABBREVIATIONS
AEVA, aqueous extract of velvet antler;
BHT, butylated hydroxytoluene;
CMP, cytidine monophosphate;
DPPH, 2,2-diphenyl-1-picrylhydrazyl;
Ferrozine, 3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine-4′,4′′disulfonic acid sodium salt; FRAP, ferric reducing
antioxidant power;
HPLC, high-performance liquid chromatography;
MS, mass spectrometry;
TPTZ, 2,4,6-tris(2-pyridyl)-s-triazine;
Trolox, 6-hydroxy-2,5,7,8-tetramethylchromane-2carboxylic acid;
UMP, uridine monophosphate.
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